Curriculum · Gynecology / Women's Health / Infertility / Perinatal Care / Birth Spacing
Hypertension during lactation
What it is
Hypertension that was present in pregnancy does not end with the birth, and the woman who has just delivered is still the patient she was before it. The classification itself is written around the postpartum period, so the label she goes home with is decided after delivery, not before:
- Chronic HTN: present before pregnancy or diagnosed before 20 weeks gestation, or persisting beyond 12 weeks postpartum
- Gestational HTN: new hypertension at or after 20 weeks gestation without proteinuria, with BP normal by 12 weeks postpartum; it could be a harbinger of chronic hypertension later in life
- Preeclampsia: increased BP with proteinuria; eclampsia is preeclampsia with seizures
- Chronic hypertension with superimposed preeclampsia
So blood pressure typically normalizes within 12 weeks postpartum, and persistent BP elevation postpartum beyond 12 weeks suggests chronic hypertension.
How long she is watched
Monitor BP for at least 72 hours postpartum and again at 7-10 days. Continue antihypertensives if needed. Educate on the signs of postpartum pre-eclampsia, for example severe headache and vision changes. Follow up with a healthcare provider to reassess long-term cardiovascular risk.
The reason for the long watch is written twice: BP should be monitored closely in the postpartum period because gestational hypertension increases the risk of postpartum hypertension, and long-term follow-up is needed because of the increased risk of chronic hypertension and cardiovascular disease later in life.
Which drug she goes home on
The one clear postnatal drug instruction in the files is about methyldopa: if a woman has taken methyldopa to treat chronic hypertension during pregnancy, stop it within 2 days of birth and restart the antihypertensive treatment the woman was taking before pregnancy. The reason given for stopping it is the risk of postnatal depression. So methyldopa is a pregnancy drug that is stopped at the birth.
The drugs of pregnancy itself, which is the frame the question is usually set in:
- Women with hypertension who become pregnant, or are planning to become pregnant, should be transitioned to methyldopa, nifedipine and/or labetalol
- Labetalol is the drug of choice, and oral labetalol is first-line following the 2010 NICE guidelines; methyldopa and nifedipine are the suitable alternatives, and hydralazine may also be used
- Methyldopa is contraindicated in depression, and a beta blocker is contraindicated in asthma, which is how the question takes you off labetalol and onto nifedipine
- Women with hypertension who become pregnant should not be treated with ACE inhibitors, ARBs or direct renin inhibitors. ACE inhibitors should not be used to treat hypertension during pregnancy as they are teratogenic and affect fetal urine production; lisinopril is fetotoxic and should not be given. In eclampsia or preeclampsia, ACE inhibitors, ARBs, renin inhibitors and nitroprusside are contraindicated
- Before pregnancy: stop ACE inhibitors and ARBs within 2 days of notification of pregnancy and start labetalol or aldomet; atenolol should be discontinued when pregnancy is diagnosed; there may be an increased risk of congenital abnormalities and neonatal complications if chlorothiazide is taken during pregnancy
The files do not say what happens to an ACE inhibitor once the baby is delivered; what they say is that the pre-pregnancy treatment is restarted.